Cargando…

The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells

PURPOSE: P-glycoprotein mediated efflux is one of the main mechanisms for multidrug resistance in cancers, and 3-Bromopyruvate acts as a promising multidrug resistance reversal compound in our study. To test the ability of 3-Bromopyruvate to overcome P-glycoprotein-mediated multidrug resistance and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Long, Xu, Jun, Yuan, Weiqi, Wu, Baojian, Wang, Hao, Liu, Guangquan, Wang, Xiaoxiong, Du, Jun, Cai, Shaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221289/ https://www.ncbi.nlm.nih.gov/pubmed/25372840 http://dx.doi.org/10.1371/journal.pone.0112132

Ejemplares similares

Preparation of psoralen polymer–lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
por: Huang, Qingqing, et al.
Publicado: (2018)

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014)

Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7(ADR) breast cancer cells
por: Abdel-Sattar, Ola E., et al.
Publicado: (2023)

Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
por: Chen, Yuan-Yuan, et al.
Publicado: (2016)

Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier
por: Li, Jin-Ming, et al.
Publicado: (2015)

Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
por: Wei, Jinrong, et al.
Publicado: (2014)

Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway
por: Yang, Lin, et al.
Publicado: (2020)

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
por: Wang, Chao, et al.
Publicado: (2015)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
por: Shao, Wenna, et al.
Publicado: (2023)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
por: Abdelaziz, Mohammed H., et al.
Publicado: (2023)

Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.
por: Budworth, J., et al.
Publicado: (1997)

Enhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro
por: Teng, Yanwei, et al.
Publicado: (2015)

Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma
por: Zhang, Lu, et al.
Publicado: (2016)

Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
por: Budworth, J., et al.
Publicado: (1996)

Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
por: Wang, Changyuan, et al.
Publicado: (2016)

In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes
por: Xin, Qi, et al.
Publicado: (2019)

Compound 968 reverses adriamycin resistance in breast cancer MCF-7(ADR) cells via inhibiting P-glycoprotein function independently of glutaminase
por: Yang, Ronghui, et al.
Publicado: (2021)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
por: Miri, Ali, et al.
Publicado: (2023)

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
por: Li, Ying, et al.
Publicado: (2017)

Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells
por: Jeon, Yong-Joon, et al.
Publicado: (2016)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

In Vitro Cytotoxic Study of Euphorbia grantii Oliv. Aerial Parts against MCF-7 and MCF-7(ADR) Breast Cancer Cell Lines: A Bioactivity-Guided Isolation
por: Radi, Mai Hussin, et al.
Publicado: (2023)

Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cells
por: Xu, Feifei, et al.
Publicado: (2020)

A Novel Submicron Emulsion System Loaded with Doxorubicin Overcome Multi-Drug Resistance in MCF-7/ADR Cells
por: Zhou, W. P., et al.
Publicado: (2015)

Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells
por: Liu, Ming, et al.
Publicado: (2016)

Prenylflavonoid Isoxanthohumol Sensitizes MCF-7/ADR Cells to Doxorubicin Cytotoxicity via Acting as a Substrate of ABCB1
por: Liu, Ming, et al.
Publicado: (2017)

Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations
por: Chen, Xiujie, et al.
Publicado: (2013)

PA‐MSHA inhibits the growth of doxorubicin‐resistant MCF‐7/ADR human breast cancer cells by downregulating Nrf2/p62
por: Wei, Yingze, et al.
Publicado: (2016)

Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells
por: Jia, Nan, et al.
Publicado: (2017)

Trichostatin A reverses epithelial-mesenchymal transition and attenuates invasion and migration in MCF-7 breast cancer cells
por: Wang, Xiaoxiong, et al.
Publicado: (2020)

CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy
por: Zhu, Z., et al.
Publicado: (2021)

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line
por: Li, Jie, et al.
Publicado: (2001)

Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin
por: Abdalla, Ashraf N., et al.
Publicado: (2021)

3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis
por: Jagielski, Tomasz, et al.
Publicado: (2018)

Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins
por: Pan, Xia, et al.
Publicado: (2017)

Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation
por: Zhou, Qianqian, et al.
Publicado: (2019)

Construction and Evaluation of Folic Acid-Modified 3-Bromopyruvate Cubosomes
por: Hou, Fangyan, et al.
Publicado: (2020)

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis
por: Wang, Wenjing, et al.
Publicado: (2019)

Transport of 3-bromopyruvate across the human erythrocyte membrane
por: Sadowska-Bartosz, Izabela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n7l55ahjebab5v93c04ocrcc92